Tag: EU Annex 11

Addressing Common Errors in the Review and Approval of Electronic Records In the pharmaceutical industry, ensuring the integrity of electronic records and electronic signatures (ERES) is critical for regulatory compliance…

Effective Management of Hybrid Paper and Electronic Signature Workflows The transition to hybrid workflows combining paper and electronic signatures poses significant challenges for pharmaceutical companies striving to maintain compliance in…

A Case Study in ERES Validation for eQMS, LIMS, MES, and CDS Platforms In the rapidly evolving pharmaceutical landscape, ensuring the integrity and compliance of electronic records and electronic signatures…

Minimizing Risks Associated with Electronic Signature Delegation in Pharma Quality Systems As the pharmaceutical industry increasingly adopts electronic records and electronic signatures (ERES), the need for stringent oversight in quality…

Steps to Demonstrate Compliance with ERES in LIMS and CDS Platforms In today’s pharmaceutical landscape, maintaining compliance with regulations governing electronic records and electronic signatures is critical. Especially with the…

Developing an Effective Retention Strategy for Electronic Records in GMP Settings In the pharmaceutical industry, the management of electronic records and electronic signatures is critical for compliance and operational efficiency.…

Controlling Access in Electronic Records Systems: Practical Solutions for Compliance Risks In the evolving landscape of pharmaceutical manufacturing and quality assurance, securing electronic records and electronic signatures (ERES) is paramount…

Case Study: Investigating Failures in Electronic Records and Signatures during Pharma Inspections In the realm of pharmaceutical manufacturing, adherence to regulatory standards surrounding electronic records and electronic signatures (ERES) is…

Understanding Electronic Signatures: Ensuring Compliance and Integrity in Pharma Operations In the pharmaceutical sector, the integrity of processes is paramount; however, the implementation of electronic records and electronic signatures (ERES)…

Creating Effective Audit Trails for Electronic Record Integrity The integrity of electronic records is a common concern in pharmaceutical manufacturing and quality assurance. As companies transition to digital solutions, the…

Essential Control Strategies for Electronic Records and Electronic Signatures in Pharma The adoption of electronic records and electronic signatures (ERES) within pharmaceutical operations brings several advantages, such as improved efficiency…

Addressing Compliance with 21 CFR Part 11 for Electronic Records In the evolving landscape of pharmaceutical manufacturing, compliance with regulatory standards is paramount, particularly in the realm of electronic records…